Glycated hemoglobin and related factors in diabetic children and adolescents under 18 years of age: A Belgian experience

Diabetes Care

Volumn 20, Issue 1, 1997, Pages 2-6

  Dorchy, Harry ^a   Roggemans, Marie Paule ^a   Willems, Dominique ^b  

^a HOP UNIV DES ENFANTS REINE FABIOLA   (Belgium)

^b BRUGMANN UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED HEMOGLOBIN;

ADOLESCENT; ARTICLE; BELGIUM; BODY MASS; CHILD; CONTROLLED STUDY; DIABETES CONTROL; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HOME MONITORING; HUMAN; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; OBESITY; SEX DIFFERENCE;

EID: 0031034392     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.20.1.2     Document Type: Article

References (20)

1. Strowig SM, Raskin P: Glycemic control and the complications of diabetes: after the Diabetes Control and Complications Trial. Diabetes Rev 3:237-257, 1995
2. Clark CM, Lee DA: Prevention and treatment of the complications of diabetes mellitus. N Engl J Med 332:1210-1217, 1995
3. 1c can be achieved in young diabetic patients beyond the honeymoon period? Diabetes Care 16:1311-1313, 1993
4. Dorchy H: Quel contrôle glycémique peut etre obtenu chez des jeunes diabétiques sans sécrétion résiduelle d'insuline endogène? Quelle est la fréquence des hypoglycémies sévères et des complications subcliniques? Arch Pediatr 1:970-981, 1994
5. Diabetes Control and Complications Trial Research Group: Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. J Pediatr 125:177-188, 1994
6. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
7. Dorchy H, Vandewalle C, Decraene T, Nagy ZP, Schuit F, Gorus F, Belgian Diabetes Registry: Genetic and immunological markers in European Caucasians and Mograbin Caucasians with type I (insulin-dependent) diabetes residing in Belgium. Pediatr Adolesc Endocrinol 23:71-75, 1993
8. Dorchy H: Dorchy's recipes explaining the "intriguing efficacy of Belgian insulin therapy". Diabetes Care 17:458-460, 1994
9. Czernichow P, Dorchy H: Diabétologie Pédiatrique. Paris, Doin, 1989
10. Dorchy H, Poortmans J: Juvenile diabetes and sports. In The Child and Adolescent Athlete. Bar-Or O, Ed. Oxford, U.K., Blackwell Science, 1996, p. 455-479
11. Dorchy H: Traitement du diabète de type I chez l'enfant et l'adolescent. Rev Prat 46:577-586, 1996
12. European IDDM Policy Group: Consensus guidelines for the management of insulin-dependent (type I) diabetes mellitus. Diabet Med 10:990-1005, 1993
13. Dorchy H, Roggemans MP, Willems D: Quel contrôle glycémique peut être obtenu chez des jeunes diabétiques et quelle est la fréquence des complications subcliniques? Avec 4 ans de recul supplémentaire. Arch Pediatr 3:294-296, 1996
14. Orchard TJ, Dorman JS, Maser RE, Becker DJ, Ellis D, LaPorte RE, Kuller LH, Wolfson SK, Drash A: Factors associated with avoidance of severe complications after 25 yr of IDDM. Diabetes Can 13:741-747, 1990
15. Kostraba JN, Dorman JS, Orchard TJ, Becker DJ, Ohki Y, Ellis D, Doft BH, Lobes LA, LaPorte RE, Drash AL: Contribution of diabetes duration before puberty to development of microvascular complications in IDDM subjects. Diabetes Care 12:686-693, 1989
16. McNally PG, Raymond NT, Swift PGF, Hearnshaw JR, Burden AC: Does the pre-pubertal duration of diabetes influence the onset of microvascular complications? Diabet Med 10:906-908, 1993
17. Dorchy H, Van Vliet G, Toussaint D, Ketelbant-Balasse P, Loeb H: Mauriac syndrome: three cases with angiofluorescein study. Diabete Metab 5:195-200, 1979
18. The Diabetes Control and Complications Trial Research Group: Adverse events and their association with treatment regimens in the diabetes control and complications trial. Diabetes Care 18:1415-1424, 1995
19. The Diabetes Control and Complications Trial Research Group: Resource utilization and costs of care in the Diabetes Control and Complications Trial. Diabetes Care 18:1468-1478, 1995
20. Tubiana-Rufi, Moret L, Czernichow P, Chalow J, The PEDIAB Collaborative Group: Risk factors for poor glycemic control in diabetic children in France. Diabetes Care 18:1479-1482, 1995